By Drug Target Review2025-09-17T09:00:44
A new experimental stem cell therapy shows promise in repairing brain damage after ischemic strokes – potentially allowing for the development of future treatments that extend the recovery window.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-30T09:54:00Z
2026-03-27T13:06:00Z
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2023-01-16T10:21:42
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2024-02-01T11:52:50
Sponsored by Leica Microsystems
Site powered by Webvision Cloud